Back to results

CompletedPhase 4

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

NCT00143026

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Royal Adelaide Hospital

Adelaide, Australia

+17 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2005-07
Enrollment: 184 participants
Sponsor: Novartis
Purpose: treatment

Locations (18)

Royal Adelaide HospitalAdelaide, Australia
Watkins Medical CenterBrisbane, Australia
Central Coast Neuroscience ResearchGosford, Australia
Heidelberg Repatriation HospitalMelbourne, Australia
Monash Medical CentreMelbourne, Australia
Sir Charles Gairdner HospitalPerth, Australia
Concord HospitalSydney, Australia
Southern Neurology, St. George Private HospitalSydney, Australia
Westmead HospitalSydney, Australia
St. Luke's Medical CentreManila, Philippines
University of Santo Tomas HospitalManila, Philippines
Chang Gung Memorial HospitalLinkou District, Taiwan
Kaohsiung Medical University, Chung-Ho Memorial HospitalLinkou District, Taiwan
National Taiwan University HospitalLinkou District, Taiwan
King Chulalongkorn Memorial HospitalBangkok, Thailand
Maharaj Nakorn Chiangmai HospitalBangkok, Thailand
Pharmongkutklao Army HospitalBangkok, Thailand
Siriraj HospitalBangkok, Thailand

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States — TrialFind